androstane-3,17-diol has been researched along with Adrenoleukodystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blasevich, M; Petroni, A; Uziel, G | 1 |
| Blasevich, M; Cappa, M; Carissimi, R; Petroni, A; Uziel, G | 1 |
2 other study(ies) available for androstane-3,17-diol and Adrenoleukodystrophy
| Article | Year |
|---|---|
Effects of the testosterone metabolite dihydrotestosterone and 5 alpha-androstan-3 alpha,17 beta-diol on very long chain fatty acid metabolism in X-adrenoleukodystrophic fibroblasts.
Topics: Adrenoleukodystrophy; Androstane-3,17-diol; Cells, Cultured; Child; Cholesterol Esters; Dihydrotestosterone; Fatty Acids; Fibroblasts; Humans; Lipid Metabolism; Oxidation-Reduction; Peroxisomes; Skin | 2003 |
Effect of testosterone metabolites on ABC half-transporter relative gene expression in X-linked adrenoleukodystrophy.
Topics: Adrenoleukodystrophy; Androgens; Androstane-3,17-diol; ATP Binding Cassette Transporter, Subfamily D; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Case-Control Studies; Cells, Cultured; Dihydrotestosterone; Exons; Fibroblasts; Gene Expression Regulation; Humans; Male; Mutation; RNA, Messenger; Severity of Illness Index; Testosterone | 2007 |